Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
ISO 28077:2006 Photocarcinogenesis Action Spectrum (Non-Melanoma Skin Cancers)
CIE S 019/E:2006 reference action spectrum for UV-induced skin cancer risk assessment
ISO 28077:2006 (also designated CIE S 019/E:2006) defines the reference action spectrum for photocarcinogenesis of non-melanoma skin cancers, establishing the wavelength-dependent effectiveness of ultraviolet radiation in inducing basal cell carcinoma and squamous cell carcinoma. This standard provides a critical biological weighting function for UV risk assessment, sunscreen efficacy testing, photobiological safety evaluation of artificial UV sources, and occupational exposure limit determination.
The photocarcinogenesis action spectrum is distinct from the erythema (sunburn) action spectrum (ISO 17166/CIE S 007). While erythema peaks sharply at 298 nm, photocarcinogenesis shows significant biological response across a broader UVB and UVA wavelength range, with important implications for comprehensive UV protection strategies.
Action Spectrum Definition and Biological Basis
The ISO 28077 action spectrum is derived from a rigorous meta-analysis of hairless mouse photocarcinogenesis studies combined with human epidemiological data, providing the best available scientific estimate of wavelength-dependent skin cancer risk across the ultraviolet spectrum from 250 nm to 400 nm. The spectrum encompasses the UVC region (250-280 nm, mostly filtered by atmospheric ozone), the UVB region (280-315 nm, the most carcinogenic per unit dose), and the UVA region (315-400 nm, lower per-unit effectiveness but present at much higher intensity in terrestrial sunlight and penetrating deeper into the skin).
| Wavelength Range | UV Subtype | Relative Carcinogenic Effectiveness | Primary Mechanism |
|---|---|---|---|
| 250-290 nm | UVC (mostly absorbed by ozone layer) | 0.5 to 1.0 (highest per photon) | Direct DNA absorption forming cyclobutane pyrimidine dimers (CPDs) |
| 290-320 nm | UVB | 1.0 at 298 nm, declining to 0.01 at 320 nm | Direct DNA damage: CPDs and 6-4 photoproducts |
| 320-340 nm | UVA-II | 0.01 declining to 0.001 | Oxidative DNA damage via reactive oxygen species (ROS) |
| 340-400 nm | UVA-I | 0.001 declining to 0.0001 | Indirect DNA damage via endogenous photosensitizers |
Although UVA radiation is 100 to 1000 times less effective per unit dose than UVB in inducing skin cancer, terrestrial sunlight contains approximately 20 times more UVA than UVB irradiance. This means UVA contributes significantly to total cumulative carcinogenic risk, with deeper skin penetration affecting basal stem cells.
Applications in Sunscreen Testing and Broad-Spectrum UV Protection
The ISO 28077 action spectrum serves as the biological weighting function for the critical wavelength determination method specified in ISO 24443 for sunscreen broad-spectrum protection evaluation. Sunscreens must demonstrate a critical wavelength of at least 370 nm to claim broad-spectrum protection, ensuring balanced protection across the full UV spectrum. The action spectrum also informs material design for UV-protective clothing, architectural glazing, automotive window films, and personal protective equipment for outdoor workers.
The ISO 28077 action spectrum has driven the development of broad-spectrum UV protection standards worldwide. Products providing balanced protection across 290-400 nm are now required to carry broad-spectrum labeling claims on consumer packaging.
UV Hazard Assessment for Artificial Sources and Occupational Exposure
ISO 28077 is referenced in conjunction with IEC 62471/CIE S 009 for photobiological safety of lamps, ICNIRP guidelines for occupational UV exposure, and regulatory frameworks for tanning equipment. The action spectrum weights the spectral output of artificial UV sources to calculate the effective carcinogenic UV dose, essential for risk assessment of welding arcs, medical phototherapy devices, UV curing systems, and cosmetic tanning units.
Q: Why is the photocarcinogenesis action spectrum different from the erythema action spectrum?
A: The two spectra differ significantly in the UVA region because different chromophores and biological pathways are involved. Using the erythema spectrum for cancer risk assessment would underestimate UVA carcinogenic risk by a factor of approximately 2-3.
A: The two spectra differ significantly in the UVA region because different chromophores and biological pathways are involved. Using the erythema spectrum for cancer risk assessment would underestimate UVA carcinogenic risk by a factor of approximately 2-3.
Q: Does ISO 28077 also apply to melanoma skin cancer risk assessment?
A: The standard specifically addresses non-melanoma skin cancers only. The action spectrum for melanoma involves different mechanisms and remains under active scientific investigation.
A: The standard specifically addresses non-melanoma skin cancers only. The action spectrum for melanoma involves different mechanisms and remains under active scientific investigation.
Regulatory Applications and International Standards Alignment
ISO 28077 is referenced by multiple regulatory frameworks worldwide. The European Commission’s recommendation on UV protection for outdoor workers uses the action spectrum for risk assessment. The US Federal Trade Commission references it in sunscreen testing guidance. The International Commission on Non-Ionizing Radiation Protection uses it as the basis for occupational UV exposure limits, recommending a daily limit of 30 J/m² effective carcinogenic dose weighted by the ISO 28077 spectrum. Australia and New Zealand incorporate it in their joint standard for solar UV protection.
The action spectrum also underpins the UV Index reporting system used by meteorological agencies worldwide. The UV Index is calculated by weighting the global solar spectral irradiance by the ISO 28077 action spectrum and integrating across UV wavelengths. This provides the public with a standardized measure of UV risk that accounts for both UVB and UVA contributions to skin cancer risk.
Q: How does ISO 28077 relate to the UV Index?
A: The UV Index uses the ISO 28077 action spectrum as its biological weighting function. The spectral irradiance at each wavelength is multiplied by the action spectrum value and integrated to produce the UV Index value.
A: The UV Index uses the ISO 28077 action spectrum as its biological weighting function. The spectral irradiance at each wavelength is multiplied by the action spectrum value and integrated to produce the UV Index value.
Q: What other ISO standards reference the photocarcinogenesis action spectrum?
A: ISO 24443 (sunscreen broad-spectrum testing), ISO 24444 (SPF testing), and ISO 17166 (erythema action spectrum) all reference or relate to ISO 28077.
A: ISO 24443 (sunscreen broad-spectrum testing), ISO 24444 (SPF testing), and ISO 17166 (erythema action spectrum) all reference or relate to ISO 28077.
Research Basis and Ongoing Scientific Validation
The ISO 28077 action spectrum is based on a comprehensive analysis of experimental photocarcinogenesis data from hairless mouse studies conducted over several decades. The standard includes a detailed description of the data selection criteria, statistical analysis methods, and modeling approaches used to derive the action spectrum. Ongoing research continues to refine the understanding of wavelength-dependent UV carcinogenesis, particularly in the UVA region, and future revisions of the standard may incorporate new scientific evidence as it becomes available.
Practical Implications for Sun Protection Recommendations
The ISO 28077 action spectrum has practical implications for daily sun protection recommendations. Public health authorities use the spectrum to determine the times of day and seasons when UV protection is necessary, to develop skin cancer prevention campaigns targeting specific population groups, and to evaluate the effectiveness of public health interventions. The action spectrum also informs the design of UV warning systems that alert the public when UV levels exceed safe thresholds.
